Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Avot...

Paylslyone:

This is exactly at the core of Avot's strength. I am very interested in how well they leverage this strength. Based on my monitoring of news reports and analylist's comments, the market for mobile devices remains healthy, and if this continues, I am hopeful that Avot will push through as one of the leaders of their pack. Since we (PTSC) have only begun our involvement with Avot, it is still difficult to find more than hope to go on (meaning there is a lack of fundamental information to evaluate), but I believe I see the potential for upward success in the year ahead and look forward to the development of this branch of PTSC's investment.

DG

Share
New Message
Please login to post a reply